APA (7th ed.) Citation

Alrefaei, A. F., & Elbeeh, M. E. Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study. MDPI AG.

Chicago Style (17th ed.) Citation

Alrefaei, Abdulmajeed F., and Mohamed E. Elbeeh. Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study. MDPI AG.

MLA (9th ed.) Citation

Alrefaei, Abdulmajeed F., and Mohamed E. Elbeeh. Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study. MDPI AG.